Latest filing published 24 Mar 2020 for EXAGEN INC..
Insider track record
Tullis Dickerson Capital Focus III, L.P.: trading record in brief
Tullis Dickerson Capital Focus III, L.P. has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Interpharm Holdings Inc and Exagen Inc. The record holds 9 filings, for trades running from 8 August 2006 to 20 March 2020.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 24 March 2020, reports a transaction in Exagen Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Tullis Dickerson Capital Focus III, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 164,420 shares0Common StockSEC:0001209191-20-021042:0
- 1,786,853 shares0Common StockSEC:0000899243-19-024086:2
- 11,498 shares@ US$14.323550.0% of flowCommon StockSEC:0000899243-19-024086:0
- 8,865 shares@ US$18.5850.0% of flowCommon StockSEC:0000899243-19-024086:1
- 63,086 shares@ US$1.2351Common Stock, par value $0.01 ("Common Stock")SEC:0000902664-08-001467:0
- 141,045 shares@ US$1.4623Common StockSEC:0000902664-08-001467:1
- 94,032 shares@ US$2.1934Common StockSEC:0000902664-08-001467:2
- 122,273 shares@ US$1.6868Common StockSEC:0000902664-08-001467:3
- 148,211 shares@ US$1.3916Common StockSEC:0000902664-08-001467:4
9 of 9 declarations
